Investors & Media

Mar 05, 2018 International Stem Cell Corporation Completes Dosing Of Second Cohort In Parkinson's Disease Clinical Trial

Jan 22, 2018 International Stem Cell Corporation is Valued at $33 Million Market Value by Edison Investment Research

Jan 11, 2018 International Stem Cell Corporation Treated Real Estate Icon Kevin Weeks

Nov 29, 2017 International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease

Nov 17, 2017 International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017

Nov 13, 2017 International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial

Nov 08, 2017 International Stem Cell Corporation to Present Six-Month Results of Neural Stem Cell Transplantation for Parkinson's Disease at Neuroscience 2017

Oct 31, 2017 International Stem Cell Corporation Receives Key Stem Cell Patent in Australia

Oct 09, 2017 International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases

Sep 26, 2017 International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials

1 2 3 4 5 6 7 8 9

<< < > >>